Business Description
Nath Bio-Genes (India) Ltd
ISIN : INE448G01010
Total Employee Number:
451Compare
Compare
Traded in other countries / regions
537291.India IPO Date
2014-01-28Description
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities; and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.73 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | 2.09 | |||||
Interest Coverage | 3.03 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.46 | |||||
Beneish M-Score | -2.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.3 | |||||
3-Year EBITDA Growth Rate | 7 | |||||
3-Year EPS without NRI Growth Rate | -0.3 | |||||
3-Year Book Growth Rate | 5.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.79 | |||||
9-Day RSI | 44.59 | |||||
14-Day RSI | 44.71 | |||||
3-1 Month Momentum % | 0.03 | |||||
6-1 Month Momentum % | 19.72 | |||||
12-1 Month Momentum % | -10.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.97 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.61 | |||||
Days Inventory | 662.08 | |||||
Days Sales Outstanding | 96.67 | |||||
Days Payable | 169.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.25 | |||||
Dividend Payout Ratio | 0.1 | |||||
Forward Dividend Yield % | 1.25 | |||||
5-Year Yield-on-Cost % | 1.29 | |||||
Shareholder Yield % | -5.72 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.73 | |||||
Operating Margin % | 10.89 | |||||
Net Margin % | 9.35 | |||||
EBITDA Margin % | 14.89 | |||||
FCF Margin % | -3.5 | |||||
OCF Margin % | -2.82 | |||||
ROE % | 6.23 | |||||
ROA % | 3.98 | |||||
ROIC % | 5.64 | |||||
3-Year ROIIC % | -4.41 | |||||
ROC (Joel Greenblatt) % | 10.96 | |||||
ROCE % | 9.07 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 7.61 | |||||
PE Ratio without NRI | 8.18 | |||||
Shiller PE Ratio | 8.59 | |||||
PS Ratio | 0.68 | |||||
PB Ratio | 0.44 | |||||
Price-to-Tangible-Book | 0.45 | |||||
EV-to-EBIT | 3.25 | |||||
EV-to-EBITDA | 3.06 | |||||
EV-to-Revenue | 0.45 | |||||
EV-to-FCF | -13.52 | |||||
Price-to-GF-Value | 0.64 | |||||
Price-to-Projected-FCF | 0.48 | |||||
Price-to-Median-PS-Value | 0.44 | |||||
Price-to-Graham-Number | 0.4 | |||||
| Price-to-Net-Current-Asset-Value | 0.84 | |||||
Earnings Yield (Greenblatt) % | 30.76 | |||||
FCF Yield % | -5.14 | |||||
Forward Rate of Return (Yacktman) % | 9.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nath Bio-Genes (India) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 4,451.015 | ||
| EPS (TTM) (₹) | 21.03 | ||
| Beta | 1.9366 | ||
| 3-Year Sharpe Ratio | -0.05 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 62.79 | ||
| 14-Day RSI | 44.71 | ||
| 14-Day ATR (₹) | 4.901966 | ||
| 20-Day SMA (₹) | 163.2325 | ||
| 12-1 Month Momentum % | -10.53 | ||
| 52-Week Range (₹) | 126.75 - 207 | ||
| Shares Outstanding (Mil) | 19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nath Bio-Genes (India) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nath Bio-Genes (India) Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 2.000000 Cash Dividend | 2025-08-14 | 175.65 (-1.32%) | ||
| INR 2.000000 Cash Dividend | 2024-08-09 | 224.25 (-4.17%) |
Show
Entries
Nath Bio-Genes (India) Ltd Frequently Asked Questions
What is Nath Bio-Genes (India) Ltd(BOM:537291)'s stock price today?
The current price of BOM:537291 is ₹159.75. The 52 week high of BOM:537291 is ₹207.00 and 52 week low is ₹126.75.
When is next earnings date of Nath Bio-Genes (India) Ltd(BOM:537291)?
The next earnings date of Nath Bio-Genes (India) Ltd(BOM:537291) is .
Does Nath Bio-Genes (India) Ltd(BOM:537291) pay dividends? If so, how much?
The Dividend Yield %  of Nath Bio-Genes (India) Ltd(BOM:537291) is 1.25% (As of Today), Highest Dividend Payout Ratio of Nath Bio-Genes (India) Ltd(BOM:537291) was 0.11. The lowest was 0.1. And the median was 0.11. The  Forward Dividend Yield % of Nath Bio-Genes (India) Ltd(BOM:537291) is 1.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nath Bio-Genes (India) Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers